Pharmarise Holdings Faces Profitability Challenges

Pharmarise Holdings Corp. (JP:2796) has released an update.

Pharmarise Holdings Corp. reports a 13.1% increase in net sales but a significant decline in profitability in the first three months of fiscal 2025, with operating and ordinary profits plunging by 84.1% and 93.0% respectively. The company’s overall financial position shows a slight decrease in total assets and net assets compared to the end of the previous fiscal year. Furthermore, Pharmarise projects modest growth in net sales but a sharp decrease in profit for the first half of the fiscal year, followed by a conservative full-year forecast.

For further insights into JP:2796 stock, check out TipRanks’ Stock Analysis page.